VIRAMUNE Side Effects

6867761-3 | Abortion Induced, Rash
on Jul 13, 2010 Female patient from , 33 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced, rash (What is rash?). Viramune dosage: 200 Mg. During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), COMBIVIR (2 Df) (View Combivir Review and Combivir Label ), EFAVIRENZ (600 Mg) (View Efavirenz Review and Efavirenz Label ), ABACAVIR SULFATE AND LAMIVUDINE (View Abacavir Sulfate And Lamivudine Review and Abacavir Sulfate And Lamivudine Label ), ZIAGEN (View Ziagen Review and Ziagen Label ).

6850064-0 | Foot Deformity
Patient was taking Viramune (View Usage). Patient had the following side effects: foot deformity on Jul 07, 2010 from Additional patient health information: Male patient , weighting 5.29 lb, . Viramune dosage: . During the same period patient was treated with LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ).

6836570-3 | Colon Cancer
Adverse event was reported on Jul 05, 2010 by a Male patient taking Viramune (View Usage) (Dosage: 400 Mg) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 69 years of age, weighting 137.8 lb, After Viramune was administered, patient had the following side effects: colon cancer. Patient was hospitalized.

6819294-8 | Threatened Labour
on Jun 28, 2010 Female patient from , weighting 141.1 lb, was diagnosed with hiv infection (What is hiv infection?), herpes virus infection and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: threatened labour. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ). Patient was hospitalized.


6819293-6 | Hepatitis, Rash
on Jul 01, 2010 Female patient from , 47 years of age, weighting 154.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?), rash (What is rash?). Viramune dosage: . During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ), CYCLIZINE (View Cyclizine Review and Cyclizine Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), KIVEXA (View Kivexa Review and Kivexa Label ), NULYTELY (View Nulytely Review and Nulytely Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), SENNA (View Senna Review and Senna Label ). Patient was hospitalized.

6815497-7 | Intestinal Functional Disorder
Patient was taking Viramune (View Usage). After Viramune was administered, patient had the following side effects: intestinal functional disorder on Jun 24, 2010 from Additional patient health information: Female patient , weighting 5.91 lb, . Viramune dosage: 400 Mg. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6790055-1 | Cholestasis, Cytolytic Hepatitis
Adverse event was reported on Jun 16, 2010 by a Male patient taking Viramune (View Usage) (Dosage: 400 Mg) was diagnosed with hiv infection cdc category a2 (What is hiv infection cdc category a2?) and. Location: , 44 years of age, Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis. During the same period patient was treated with ATRIPLA (600 Mg/200mg/245 Mg Once Daily) (View Atripla Review and Atripla Label ), TRUVADA (200mg/245mg) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6787252-8 | Cholestasis, Cytolytic Hepatitis
on Jun 16, 2010 Male patient from , 44 years of age, was diagnosed with hiv infection cdc category a2 (What is hiv infection cdc category a2?) and was treated with Viramune (View Usage). Patient had the following side effects: cholestasis, cytolytic hepatitis. Viramune dosage: 400 Mg. During the same period patient was treated with ATRIPLA (600 Mg/200mg/245 Mg Once Daily) (View Atripla Review and Atripla Label ), TRUVADA (200mg/245mg) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6785203-3 |
on Jun 22, 2010 Male patient from UNITED STATES , weighting 16.76 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). . Viramune dosage: 80 Mg Bid Oral. During the same period patient was treated with EPIVIR (30 Mg Bid 0ral) (View Epivir Review and Epivir Label ), RETROVIR (70 Mg Oral Bid) (View Retrovir Review and Retrovir Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6784395-X | Abortion Spontaneous
Patient was taking Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Jun 15, 2010 from Additional patient health information: Female patient , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: 400 Mg. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6770723-8 | Coronary Artery Disease, Coronary Artery Stenosis, Osteonecrosis, Rotator Cuff Syndrome, Umbilical Hernia
Adverse event was reported on Jun 01, 2010 by a Male patient taking Viramune (View Usage) (Dosage: 400 Mg) was diagnosed with hiv infection (What is hiv infection?), coronary artery disease (What is coronary artery disease?), hypertension, hypercholesterolaemia and. Location: , 57 years of age, weighting 200.6 lb, Patient had the following side effects: coronary artery disease (What is coronary artery disease?), coronary artery stenosis, osteonecrosis (What is osteonecrosis?), rotator cuff syndrome, umbilical hernia. During the same period patient was treated with METOPROLOL SUCCINATE (95 Mg) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), DELIX (5 Mg) (View Delix Review and Delix Label ), PRAVASTATIN (40 Mg) (View Pravastatin Review and Pravastatin Label ), TRUVADA (300/200 Mg) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6768570-6 | Laryngeal Disorder
on Jun 08, 2010 Female patient from , weighting 7.25 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: laryngeal disorder. Viramune dosage: 400 Mg. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6768470-1 | Abortion Spontaneous
on Jun 08, 2010 Female patient from , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Viramune dosage: 400 Mg. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6763188-3 | Foot Deformity
Patient was taking Viramune (View Usage). Patient had the following side effects: foot deformity on Jun 01, 2010 from Additional patient health information: Male patient , weighting 5.29 lb, . Viramune dosage: . During the same period patient was treated with LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ).

6763161-5 | Hypoaesthesia, Nausea, Nervous System Disorder
Adverse event was reported on Jun 08, 2010 by a Male patient taking Viramune (View Usage) (Dosage: 200 Mg Bid Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 205.0 lb, After Viramune was administered, patient had the following side effects: hypoaesthesia, nausea (What is nausea?), nervous system disorder.

6757895-6 | Diarrhoea, Headache, Pollakiuria, Pyrexia, Rash, Vomiting
on May 31, 2010 Male patient from , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, headache (What is headache?), pollakiuria, pyrexia, rash (What is rash?), vomiting. Viramune dosage: 400 Mg. Patient was hospitalized.

6752205-2 | Placental Disorder
on May 25, 2010 Female patient from , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient had the following side effects: placental disorder. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6745924-5 | Abortion Spontaneous
Patient was taking Viramune (View Usage). After Viramune was administered, patient had the following side effects: abortion spontaneous on May 19, 2010 from Additional patient health information: Female patient , 39 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: 400 Mg. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6744922-5 | Laryngeal Disorder
Adverse event was reported on May 18, 2010 by a Female patient taking Viramune (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: , weighting 7.25 lb, Patient experienced the following unwanted or unexpected effects: laryngeal disorder. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6744328-9 | Abortion Spontaneous
on May 20, 2010 Female patient from , 38 years of age, was diagnosed with antiviral treatment and was treated with Viramune (View Usage). Patient had the following side effects: abortion spontaneous. Viramune dosage: 0.5 Mg. During the same period patient was treated with VIREAD (245 Mg) (View Viread Review and Viread Label ).

6734010-6 | Placental Disorder
on May 12, 2010 Female patient from , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: placental disorder. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6732879-2 | Chest Pain, Myocardial Infarction
Patient was taking Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), myocardial infarction on May 12, 2010 from Additional patient health information: Male patient , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: 200 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6732877-9 | Cardiac Valve Disease, Cerebral Haemorrhage, Grand Mal Convulsion, Headache
Adverse event was reported on May 11, 2010 by a Female patient taking Viramune (View Usage) (Dosage: 400 Mg) was diagnosed with hiv infection (What is hiv infection?), heart valve replacement and. Location: , 41 years of age, weighting 110.2 lb, Patient had the following side effects: cardiac valve disease, cerebral haemorrhage, grand mal convulsion, headache (What is headache?). During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6732423-X | Placental Disorder
on May 12, 2010 Female patient from , 28 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: placental disorder. Viramune dosage: 400 Mg. During the same period patient was treated with EPZICOM (View Epzicom Review and Epzicom Label ).

6727625-2 | Cardiac Valve Disease, Cerebellar Haematoma, Cerebral Haemorrhage, Grand Mal Convulsion, Headache, Mitral Valve Disease, Subdural Haematoma, Tricuspid Valve Disease
on May 11, 2010 Female patient from , 41 years of age, weighting 110.2 lb, was diagnosed with hiv infection (What is hiv infection?), heart valve replacement and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac valve disease, cerebellar haematoma, cerebral haemorrhage, grand mal convulsion, headache (What is headache?), mitral valve disease, subdural haematoma, tricuspid valve disease. Viramune dosage: 400 Mg. During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ). Patient was hospitalized.

6726075-2 | Jaundice, Malaise
Patient was taking Viramune (View Usage). Patient had the following side effects: jaundice (What is jaundice?), malaise on May 07, 2010 from Additional patient health information: Male patient , 25 years of age, was diagnosed with hiv test positive (What is hiv test positive?) and. Viramune dosage: .

6722703-6 | Foot Deformity
Adverse event was reported on May 03, 2010 by a Male patient taking Viramune (View Usage) (Dosage: 200 Mg) . Location: , weighting 5.29 lb, After Viramune was administered, patient had the following side effects: foot deformity. During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ).

6720437-5 | Abortion Spontaneous
on May 04, 2010 Female patient from , 29 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), COMBIVIR (View Combivir Review and Combivir Label ).

6719677-0 | Cardiac Disorder, Cardiac Valve Disease, Cerebral Haemorrhage, Grand Mal Convulsion, Headache
on May 04, 2010 Female patient from , 41 years of age, weighting 110.2 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient had the following side effects: cardiac disorder, cardiac valve disease, cerebral haemorrhage, grand mal convulsion, headache (What is headache?). Viramune dosage: 400 Mg. Patient was hospitalized.

6718508-2 | Dyslipidaemia
Patient was taking Viramune (View Usage). After Viramune was administered, patient had the following side effects: dyslipidaemia on Apr 30, 2010 from Additional patient health information: Male patient , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: 200 Mg. During the same period patient was treated with TRUVADA (200mg/245 Mg) (View Truvada Review and Truvada Label ).

6716488-7 | Cholestasis, Cytolytic Hepatitis
Adverse event was reported on Apr 23, 2010 by a Male patient taking Viramune (View Usage) (Dosage: 400 Mg) was diagnosed with hiv infection cdc category a2 (What is hiv infection cdc category a2?) and. Location: , 44 years of age, Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis. During the same period patient was treated with TRUVADA (200mg/245mg) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6706625-2 | Abortion Spontaneous
on Apr 27, 2010 Female patient from , 29 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient had the following side effects: abortion spontaneous. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), COMBIVIR (View Combivir Review and Combivir Label ).

6701290-2 | Cholangitis Chronic, Factor V Leiden Mutation, Thyroid Neoplasm, Varices Oesophageal, Venous Thrombosis
on Apr 14, 2010 Male patient from , weighting 143.3 lb, was diagnosed with hiv infection (What is hiv infection?), hypercholesterolaemia and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: cholangitis chronic, factor v leiden mutation, thyroid neoplasm, varices oesophageal, venous thrombosis. Viramune dosage: 400 Mg. During the same period patient was treated with ZIAGEN (600 Mg) (View Ziagen Review and Ziagen Label ), VIDEX (300 Mg) (View Videx Review and Videx Label ), VASTEN (View Vasten Review and Vasten Label ), PERINDOPRIL (2 Mg) (View Perindopril Review and Perindopril Label ), ARIXTRA (7.5 Mg) (View Arixtra Review and Arixtra Label ). Patient was hospitalized.

6700163-9 | Virologic Failure
Patient was taking Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: virologic failure on Apr 09, 2010 from Additional patient health information: Male patient , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: .

6700161-5 | Virologic Failure
Adverse event was reported on Apr 09, 2010 by a Male patient taking Viramune (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: , 70 years of age, Patient had the following side effects: virologic failure.

6699093-0 | Stillbirth
on Apr 13, 2010 Female patient from , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: stillbirth. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6697619-4 | Alpha 1 Foetoprotein Increased, Laboratory Test Abnormal
on Apr 12, 2010 Female patient from , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: alpha 1 foetoprotein increased, laboratory test abnormal. Viramune dosage: 400mg/day. During the same period patient was treated with EPZICOM (1/day) (View Epzicom Review and Epzicom Label ), COMBIVIR (2/day) (View Combivir Review and Combivir Label ), NORVIR (200mg/day) (View Norvir Review and Norvir Label ), INVIRASE (2000 Mg) (View Invirase Review and Invirase Label ), KIVEXA (View Kivexa Review and Kivexa Label ), ABACAVIR (View Abacavir Review and Abacavir Label ), LAMIVUDINE (1 Df 2/1 Days) (View Lamivudine Review and Lamivudine Label ).

6693706-5 |
Patient was taking Viramune (View Usage). on Apr 21, 2010 from Additional patient health information: Female patient , weighting 19.97 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis, nutritional support (What is nutritional support?) and. Viramune dosage: . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), COTRIM (View Cotrim Review and Cotrim Label ), TONOFERON (COLLOIDAL IRON, FOLIC ACID, AND VITAMIN B12) (View Tonoferon (colloidal Iron, Folic Acid, And Vitamin B12) Review and Tonoferon (colloidal Iron, Folic Acid, And Vitamin B12) Label ).

6693163-9 | Abortion Spontaneous
Adverse event was reported on Apr 15, 2010 by a Female patient taking Viramune (View Usage) (Dosage: 0.5 Mg) was diagnosed with antiviral treatment and. Location: , 38 years of age, After Viramune was administered, patient had the following side effects: abortion spontaneous. During the same period patient was treated with VIREAD (245 Mg) (View Viread Review and Viread Label ).

6692269-8 | Arthralgia, Pain In Extremity
on Mar 31, 2010 Male patient from , 52 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, pain in extremity. Viramune dosage: 400 Mg. During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6692070-5 | Cholelithiasis, Lipohypertrophy
on Mar 31, 2010 Female patient from , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient had the following side effects: cholelithiasis, lipohypertrophy. Viramune dosage: . During the same period patient was treated with COMBIVIR (View Combivir Review and Combivir Label ).

6690656-5 | Liver Function Test Abnormal, Myocardial Infarction
Patient was taking Viramune (View Usage). After Viramune was administered, patient had the following side effects: liver function test abnormal, myocardial infarction on Apr 13, 2010 from Additional patient health information: Male patient , 43 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Viramune dosage: . During the same period patient was treated with LAMIVUDINE (EPIVIR HBV) (View Lamivudine (epivir Hbv) Review and Lamivudine (epivir Hbv) Label ), PLAVIX (View Plavix Review and Plavix Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6678825-1 | Blood Triglycerides Increased, Haemoglobin Decreased, Injury, Lymphocyte Count Increased, Nasopharyngitis, Pneumonia
Adverse event was reported on Apr 12, 2010 by a Female patient taking Viramune (View Usage) (Dosage: 9 Ml Bid Oral) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , child 2 years of age, weighting 19.97 lb, Patient experienced the following unwanted or unexpected effects: blood triglycerides increased, haemoglobin decreased, injury, lymphocyte count increased, nasopharyngitis, pneumonia (What is pneumonia?). During the same period patient was treated with EPIVIR (3 Ml Bid Oral) (View Epivir Review and Epivir Label ), COTRIM (View Cotrim Review and Cotrim Label ), TONOFERON (COLLOIDAL IRON, FOLIC ACID, AND VITAMIN B12) (View Tonoferon (colloidal Iron, Folic Acid, And Vitamin B12) Review and Tonoferon (colloidal Iron, Folic Acid, And Vitamin B12) Label ).

6677287-8 | Anaemia, Asthenia, Neutropenia, Pyrexia, Sinusitis
on Apr 06, 2010 Male patient from , weighting 141.1 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient had the following side effects: anaemia, asthenia, neutropenia, pyrexia, sinusitis (What is sinusitis?). Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), ISENTRESS (800 Mg) (View Isentress Review and Isentress Label ).

6676241-X | Rash
on Mar 29, 2010 Female patient from , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: rash (What is rash?). Viramune dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ).

6674984-5 | Cholestasis, Cytolytic Hepatitis
Patient was taking Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, cytolytic hepatitis on Apr 01, 2010 from Additional patient health information: Male patient , 44 years of age, was diagnosed with hiv infection cdc category a2 (What is hiv infection cdc category a2?) and. Viramune dosage: 400 Mg. During the same period patient was treated with TRUVADA (200mg/245mg) (View Truvada Review and Truvada Label ). Patient was hospitalized.

6665415-X |
Adverse event was reported on Mar 29, 2010 by a Female patient taking Viramune (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), prophylaxis, nutritional support (What is nutritional support?) and. Location: , weighting 19.97 lb, . During the same period patient was treated with LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), COTRIM (View Cotrim Review and Cotrim Label ), TONOFERON (View Tonoferon Review and Tonoferon Label ).

6658820-9 | Injection Site Cellulitis, Malaise, Pyrexia, Rash Maculo-papular
on Mar 25, 2010 Female patient from , 33 years of age, weighting 143.3 lb, was diagnosed with prophylaxis, hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). After Viramune was administered, patient had the following side effects: injection site cellulitis, malaise, pyrexia, rash maculo-papular. Viramune dosage: 200 Mg. During the same period patient was treated with PNEUMOVAX 23 (View Pneumovax 23 Review and Pneumovax 23 Label ), EFAVIRENZ (600 Mg) (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (300 Mg) (View Lamivudine Review and Lamivudine Label ), TENOFOVIR (300 Mg) (View Tenofovir Review and Tenofovir Label ).

6654591-0 | Agitation Neonatal, Anaemia Neonatal, Caesarean Section, Hypocalcaemia, Jaundice Neonatal, Lethargy, Neonatal Tachypnoea, Pyrexia
on Mar 17, 2010 Female patient from , weighting 7.67 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Viramune (View Usage). Patient experienced the following unwanted or unexpected effects: agitation neonatal, anaemia neonatal, caesarean section, hypocalcaemia, jaundice neonatal, lethargy, neonatal tachypnoea, pyrexia. Viramune dosage: 200 Mg. During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), DIDANOSINE (400 Mg) (View Didanosine Review and Didanosine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), VITAMIN K TAB (View Vitamin K Tab Review and Vitamin K Tab Label ), AZT (8 Ml) (View Azt Review and Azt Label ).

6653466-0 | Hepatitis Acute, Hepatitis Cholestatic
Patient was taking Viramune (View Usage). Patient had the following side effects: hepatitis acute, hepatitis cholestatic on Mar 22, 2010 from UNITED STATES Additional patient health information: Male patient , 48 years of age, . Viramune dosage: .